NCT05912582View on ClinicalTrials.gov

Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Stage IVa Nasopharyngeal Carcinoma

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

June 25, 2023

Primary Completion Date

June 25, 2025

Study Completion Date

December 25, 2025

Conditions
Stage IVA Nasopharyngeal Carcinoma
Interventions
RADIATION

Intensity modulated radiation therapy (IMRT) combined with chemotherapy

Intensity modulated radiation therapy (IMRT) combined with chemotherapy

Trial Locations (1)

Unknown

Jiangsu Cancer Hospital, Nanjing

All Listed Sponsors
lead

Jiangsu Cancer Institute & Hospital

OTHER

NCT05912582 - Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Stage IVa Nasopharyngeal Carcinoma | Biotech Hunter | Biotech Hunter